CD123/CLL1 CAR-T Cells for R/R AML (STPHI_0001)

NCT03631576 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Fujian Medical University